Cyclosporine metabolite cross-reactivity in different cyclosporine assays

Clinical Biochemistry

Volumn 31, Issue 3, 1998, Pages 159-163

  Murthy, Jayasimha N ^a,c   Yatscoff, Randall W ^b   Soldin, Steven J ^a,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Cross reactivity; Cyclosporine metabolites; Immunophilins; Immunosupression; Radioreceptor assay

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN DERIVATIVE; DRUG METABOLITE;

ARTICLE; CROSS REACTION; DRUG DETERMINATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANIMALS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; FLUORESCENCE POLARIZATION IMMUNOASSAY; RADIOIMMUNOASSAY; RADIOLIGAND ASSAY;

EID: 0032052182     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00007-1     Document Type: Article

References (26)

1. 1. Christians U, Sewing K. Alternative cyclosporine metabolic pathways and toxicity. Clin Biochem 1995; 28: 547-59.
2. 2. Mason J. The pathophysiology of Sandimmune(cyclosporine A in man and animals. Pediatric Nephrol 1990; 4: 554-74.
3. 3. Myers BD. Cyclosporine nephrotoxicity. Kidney Int 1986; 30: 964-74.
4. 4. Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am Journal of Kidney Dis 1996; 28: 159-72.
5. 5. Clipstone NA, Crabtree GR. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporine A and FK506. Ann N Y Acad Sci 1993; 696: 20-30.
6. 6. Kolars JC, Awni WM, Merion RM, Watkins PB. First pass metabolism of cyclosporine by the gut. Lancet 1991; 338: 1488-90.
7. 7. Vickers AEM, Fischer V, Connors S, et al. Cyclosporine A metabolism in human liver, kidney and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metab Dispos 1992; 20: 802-9.
8. 8. Christians U, Sewing K. Cyclosporine metabolism in liver transplant patients. Pharmacol Ther 1993; 57: 291-345.
9. 9. Wenger RM. Structures of cyclosporine and its metabolites. Transplant Proc 1990; 22: 1104-8.
10. 10. Rosano T, Freed B, Ceril J. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantantion 1986; 42: 262-7.
11. 11. Copeland KR, Yatscoff RW, McKenna RM. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectrometry and nuclear magnetic resonance. Clin Chem 1990; 36: 225-9.
12. 12. Sketris I, Yatscoff R, Keown P, et al. Optimizing the use of cyclosporine in renal transplantation. Clin Biochem 1995; 28: 195-211.
13. 13. Donnelly JG, Soldin SJ. Partial characterization of a 52 kDa CsA/FK506/rapamycin binding protein. Clin Biochem 1994; 27: 367-72.
14. 14. Goodyear N, Napoli KL, Murthy JN, Kahan BD, Soldin SJ. Radioreceptor assay for sirolimus. Clin Biochem 1996; 29: 457-60.
15. 15. Handschumaker RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific binding protein for cyclosporine A. Science 984; 226: 544-7.
16. 16. Harding MW, Galat A, Uehling DE, Screiber SL. A receptor for the immunosuppressant FK506 is cis-trans peptidyl-prolyl isomerase. Nature 1989; 341: 758-60.
17. 17. Soldin SJ, Murthy JN, Chen Y, Donnelly JG, Yatscoff RW. Correlation of two radioreceptor assays and the specific and nonspecific fluorescence polarization immunoassays for cyclosporine with immunosuppression as measured by the mixed lymphocyte culture assay. Trans Proc 1994; 26: 2814-17.
18. 18. Lee S, Brudzinski AM, Yasmineh JL, et al. Measurement of cyclosporine A by a specific radioimmunoassay with a monoclonal antibody and 1251 tracer. Clin Biochem 1991; 24: 43-8.
19. 19. Wang PP, Simpson E, Meucci V, et al. Cyclosporine monitoring by fluoresence polarizationimmunoassay. Clin Biochem 1991; 24: 55-8.
20. 20. Soldin SJ. Receptor assays in the clinical laboratory. Clin Biochem 1996; 29: 439-44.
21. 21. Soldin SJ. Receptor (immunophilin-binding) assay for immunosuppressive drugs. Ther Drug Monit 1995; 17: 574-6.
22. 22. Donnelly JG, Soldin SJ. A radioreceptor assay for the measurement of cyclosporine activity: a preliminary report. Ther Drug Monit 1989; 11: 696-700.
23. 23. LoRber MI, Paul K, Harding MW, Handchumacher RE, Marks WH. Cyclophilin binding: a receptor mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation. Transplant Proc 1990; 22: 1240-4.
24. 24. Huupponen R, Hirvisalo E, Neuvonen P. Comparison of cyclophilin binding assay and radioimmunoassay in monitoring of blood cyclosporine. Ther Drug Monit 1997; 19: 446-9.
25. 25. Soldin SJ, Murthy JN, Chen Y, Donnelly JG, Yatscoff RW. Correlation of two radioreceptor assays and the specific and non-specific FPIA for CsA with immunosuppression mediated by the mixed lymphocyte assay. Trans Proc 1994; 26: 2814-17.
26. 26. Murthy JN, Davis DL, Yatscoff RW, Soldin SJ. Tacrolimus Metabolite Cross-reactivity in different tacrolimus assays. Clin Biochem. In press.